A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NIPS / noninvasive prenatal screening

[Related PubMed/MEDLINE]
Total Number of Papers: 68
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NIPS  (>> Co-occurring Abbreviation)
Long Form:   noninvasive prenatal screening
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Analyzing false-negative results detected in low-risk non-invasive prenatal screening cases. ---
2020 Benefits and limitations of noninvasive prenatal aneuploidy screening. cfDNA
2020 Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening. DZ, FF, MZ, SNP
2020 Clinical performance of DNA-based prenatal screening using single-nucleotide polymorphisms approach in Thai women with singleton pregnancy. FF, PPVs, SCA, SNPs, VT
2020 Clinical utility of expanded noninvasive prenatal screening and chromosomal microarray analysis in high risk pregnancies. CMA
2020 Coverage profile correction of shallow-depth circulating cell-free DNA sequencing via multidistance learning. ccfDNA, WGS
2020 Fetal sex discordance between noninvasive prenatal screening results and sonography: A single institution's experience and review of the literature. ---
2020 High false-positive non-invasive prenatal screening results for sex chromosome abnormalities: Are maternal factors the culprit? CNV, CNV-seq, SCAs
2020 Impact of ultrasonography on identifying noninvasive prenatal screening false-negative aneuploidy. ---
10  2020 Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening. cfDNA, FF, SNPs
11  2020 Non-invasive prenatal screening for Emanuel syndrome. FISH, SNP Array, sSMC
12  2020 Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk. BMI, FF
13  2020 Prenatal Testing In Pregnancies Conceived By In Vitro Fertilization With Pre-implantation Genetic Testing. IVF, PGT-A
14  2020 Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management. ---
15  2020 [The value of noninvasive prenatal screening for the detection of fetal chromosome 16 aneuploidy]. CMA, PPV
16  2019 A gradual change of chromosome mosaicism from placenta to fetus leading to T18 false negative result by NIPS. cff DNA, CMA, CNV-seq
17  2019 Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations. ACMG
18  2019 Alternative option labeling impacts decision-making in noninvasive prenatal screening. MTurk, SWD
19  2019 An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study. cfDNA, cffDNA
20  2019 Attitudes of Israeli parents of children with Down syndrome toward non-invasive prenatal screening and the scope of prenatal testing. DS, PND
21  2019 Clinical application of noninvasive prenatal screening for sex chromosome aneuploidies in 50,301 pregnancies: initial experience in a Chinese hospital. SCAs
22  2019 Clinical evaluation of NIPS for women at advanced maternal age: a multicenter retrospective study. AMA, NPV, PPV, SCAs
23  2019 Clinical experience across the fetal-fraction spectrum for a non-invasive prenatal screen with low test-failure rate. WGS
24  2019 Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. CNV, MMS, PPVs
25  2019 Detection of fetal duplication 16p11.2q12.1 by next-generation sequencing of maternal plasma and invasive diagnosis. CMA, CNVs, FISH
26  2019 Discordant sex between fetal screening and postnatal phenotype requires evaluation. cfDNA
27  2019 Factors affecting cell-free DNA fetal fraction: statistical analysis of 13,661 maternal plasmas for non-invasive prenatal screening. cffDNA
28  2019 Fetal fraction evaluation in non-invasive prenatal screening (NIPS). ---
29  2019 Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests. CDP, PPV
30  2019 Maternal copy-number variations in the DMD gene as secondary findings in noninvasive prenatal screening. CNVs
31  2019 Prospective head-to-head comparison of accuracy of two sequencing platforms for screening for fetal aneuploidy by cell-free DNA: the PEGASUS study. DR, FPR
32  2019 Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome Measures. CI, PPVs
33  2019 The association of HBB-related significant hemoglobinopathies and low fetal fraction on noninvasive prenatal screening for fetal aneuploidy. HSH, HSH
34  2019 Uncertainty of fetal fraction determination in Non-Invasive Prenatal Screening by highly polymorphic SNPs. IQR, SNPs
35  2019 [Noninvasive prenatal screening for twin pregnancy: an analysis of 2057 cases]. NIPT
36  2018 A method for improving the accuracy of non-invasive prenatal screening by cell-free foetal DNA size selection. cfDNA, PPV, s-NIPS
37  2018 A new approach of digital PCR system for non-invasive prenatal screening of trisomy 21. cfDNA, cffDNA, dPCR
38  2018 Enrichment of the fetal fraction in non-invasive prenatal screening reduces maternal background interference. cfDNA, cffDNA, iNIPS
39  2018 False Low-Risk Single Nucleotide Polymorphism-Based Noninvasive Prenatal Screening in Pentasomy 49,XXXXY. ---
40  2018 False positive result in non-invasive prenatal screening (NIPS). ---
41  2018 Improving Single-Nucleotide Polymorphism-Based Fetal Fraction Estimation of Maternal Plasma Circulating Cell-Free DNA Using Bayesian Hierarchical Models. ccfDNA, FQAs, NGS, RMSE, SNPs, WGS
42  2018 Informative priors on fetal fraction increase power of the noninvasive prenatal screen. ---
43  2018 Mosaic maternal 10qter deletions are associated with FRA10B expansions and may cause false-positive noninvasive prenatal screening results. ---
44  2018 Strategies to minimize false positives and interpret novel microdeletions based on maternal copy-number variants in 87,000 noninvasive prenatal screens. mCNVs
45  2018 The epidemic of abnormal copy number variant cases missed because of reliance upon noninvasive prenatal screening. aCGH, CNVs, DPs
46  2018 Use of Genetic Testing after Abnormal Screening Ultrasound: A Descriptive Cohort Study. ---
47  2017 A quantitative cSMART assay for noninvasive prenatal screening of autosomal recessive nonsyndromic hearing loss caused by GJB2 and SLC26A4 mutations. ARNSHL, cSMART, IPS
48  2017 Challenges in non-invasive prenatal screening for sub-chromosomal copy number variations using cell-free DNA. CNVs
49  2017 Improving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS). ---
50  2017 In silico size selection is effective in reducing false positive NIPS cases of monosomy X that are due to maternal mosaic monosomy X. ---
51  2017 Non-invasive prenatal screening versus prenatal diagnosis by array comparative genomic hybridization: a comparative retrospective study. aCGH, NT
52  2017 Non-invasive prenatal testing. NIPT
53  2017 Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods. SNP, WGS
54  2017 Noninvasive Prenatal Screening of Fetal Aneuploidy without Massively Parallel Sequencing. HLPA, MPS
55  2017 Performance of non-invasive prenatal screening for fetal aneuploidy in twin pregnancies: a meta-analysis. LR
56  2017 Population-based impact of noninvasive prenatal screening on screening and diagnostic testing for fetal aneuploidy. cFTS
57  2017 [Analysis of non-invasive prenatal screening detection in fetal chromosome aneuploidy]. ---
58  2017 [Detection of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening of fetal chromosomal aneuploidies in women of advanced maternal age]. ---
59  2017 [Result of prenatal diagnosis for 151 high-risk women by noninvasive prenatal screening based on high-throughput sequencing]. CMA, CNVs
60  2016 Down Syndrome: Current Status, Challenges and Future Perspectives. DS
61  2016 False Negative Cell-Free DNA Screening Result in a Newborn with Trisomy 13. cfDNA, cffDNA
62  2016 Non-invasive prenatal screening for trisomy 21: Consumers' perspectives. ---
63  2016 Posttest risk calculation following positive noninvasive prenatal screening using cell-free DNA in maternal plasma. PTR
64  2015 Maternal cell-free DNA-based screening for fetal microdeletion and the importance of careful diagnostic follow-up. cfDNA
65  2015 Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings. CI, FN, PPV
66  2015 Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center. cfDNA
67  2014 Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis. CVS
68  2014 Noninvasive prenatal screening by next-generation sequencing. ---